DalsnaFinance

Elevance Health $ELV

Health Care · Managed Health Care · NYSE/NASDAQ

S&P 500 Russell 1000 Indiana
Create a scorecard
$440.18
+9.95 (+2.31%)
As of Oct 20, 2026, 9:06 PM EDT
Price history
Loading chart…
Today's analyst average Analyst average over timeIndividual analyst targets Analyst history starts Oct 12, 2026, the first target we tracked for ELV.

Key facts

52-week range (closes)
$280.74 – $426.79 Lowest close Mar 9, 2026, highest Jul 14, 2026; 251 daily closes to Oct 13, 2026 from Dalsna Finance's price archive
Fiscal year ends
December Fiscal 2025 ended Dec 31, 2025, from SEC filings
In the S&P 500 since
Jul 25, 2002 · All S&P 500 changes
Analyst coverage
1 open price target from 1 firm: Guggenheim Approved targets tracked here; see the analyst section below

Elevance Health (ELV) is trading up at $440.18 (+2.31%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.

Analyst price targets on ELV

One firm's current price target on Elevance Health: $460 — 5% above the current $440. Each is tracked to its date and scored the same way a member's call is.

Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.

Elevance Health revenue & net income history (FY2016–FY2025)

RevenueNet incomeNet margin (right axis, %)
$199.1B$99.6B$0FY2016 revenue: $84.9BFY2016 net income: $2.47B · Net margin 2.9%'16FY2017 revenue: $90.0BFY2017 net income: $3.84B · Net margin 4.3%'17FY2018 revenue: $92.1BFY2018 net income: $3.75B · Net margin 4.1%'18FY2019 revenue: $104.2BFY2019 net income: $4.81B · Net margin 4.6%'19FY2020 revenue: $121.9BFY2020 net income: $4.57B · Net margin 3.8%'20FY2021 revenue: $138.6BFY2021 net income: $6.16B · Net margin 4.4%'21FY2022 revenue: $156.6BFY2022 net income: $5.89B · Net margin 3.8%'22FY2023 revenue: $171.3BFY2023 net income: $5.99B · Net margin 3.5%'23FY2024 revenue: $177.0BFY2024 net income: $5.98B · Net margin 3.4%'24FY2025 revenue: $199.1BFY2025 net income: $5.66B · Net margin 2.8%'250%2%4%6%FY2016 net margin: 2.9%FY2017 net margin: 4.3%FY2018 net margin: 4.1%FY2019 net margin: 4.6%FY2020 net margin: 3.8%FY2021 net margin: 4.4%FY2022 net margin: 3.8%FY2023 net margin: 3.5%FY2024 net margin: 3.4%FY2025 net margin: 2.8%
Elevance Health annual financial statements
FY2016Dec 2016FY2017Dec 2017FY2018Dec 2018FY2019Dec 2019FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue$84.9B$90.0B$92.1B$104.2B$121.9B$138.6B$156.6B$171.3B$177.0B$199.1B
Growth (year over year)+7.2%+6.1%+2.3%+13.1%+16.9%+13.8%+13.0%+9.4%+3.3%+12.5%
Gross profit—$90.0B$92.1B$102.2B$112.9B$127.7B$143.6B$154.0B$157.3B$177.9B
Gross margin—100.0%100.0%98.1%92.7%92.1%91.7%89.9%88.8%89.4%
Operating income$4.80B$4.17B$5.43B$6.00B$6.36B$7.56B$8.28B$8.50B$7.86B$7.20B
Operating margin5.7%4.6%5.9%5.8%5.2%5.5%5.3%5.0%4.4%3.6%
Net income$2.47B$3.84B$3.75B$4.81B$4.57B$6.16B$5.89B$5.99B$5.98B$5.66B
Net margin2.9%4.3%4.1%4.6%3.8%4.4%3.8%3.5%3.4%2.8%
EPS (diluted)$9.21$14.35$14.19$18.47$17.98$24.95$24.28$25.22$25.68$25.21
Balance sheet
Cash and equivalents$4.08B$3.61B$3.93B$4.94B$5.74B$4.88B$7.39B$6.53B$8.29B$9.49B
Total assets$65.1B$70.5B$71.6B$77.5B$86.6B$97.5B$102.8B$108.9B$116.9B$121.5B
Total liabilities$40.0B$44.0B$43.0B$45.7B$53.4B$61.3B$66.4B$69.5B$75.5B$77.5B
Long-term debt$14.4B$17.4B$17.2B$17.8B$19.3B$21.2B$22.3B$23.2B$29.2B$30.8B
Shareholders' equity$25.1B$26.5B$28.5B$31.7B$33.2B$36.1B$36.2B$39.3B$41.3B$43.9B
Cash flow
Operating cash flow$3.27B$4.18B$3.83B$6.06B$10.7B$8.36B$8.40B$8.06B$5.81B$4.29B
Capital expenditure$584.0M$791.0M$1.21B$1.08B$1.02B$1.09B$1.15B$1.30B$1.26B$1.12B
Free cash flow$2.69B$3.39B$2.62B$4.98B$9.67B$7.28B$7.25B$6.76B$4.55B$3.17B
Dividends paid$684.0M$705.0M$776.0M$818.0M$954.0M$1.10B$1.23B$1.40B$1.51B$1.53B
Share buybacks$0$2.00B$1.69B$1.70B$2.70B$1.90B$2.32B$2.68B$2.90B$2.60B

From Elevance Health's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Elevance Health

Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.

Source: Wikipedia — Elevance Health

Headquarters
Indianapolis, Indiana From SEC filings, Oct 2026

Recent News (18)

More Health Care stocks

Browse all companies →